Michael Pellini

Adaptive Biotechnologies announced that former Foundation Medicine CEO Michael Pellini has joined its board. Pellini is currently chairman of Foundation Medicine's board, and is a managing partner of life science venture capital firm Section 32. He previously was president and chief operating officer of Clarient, which was acquired by GE Healthcare in 2010. He currently also serves on the boards of Tango Therapeutics, Singular Genomics, the Personalized Medicine Coalition, and the Mission Hospital Foundation.